MENU
MYGN
AS OF
Dec 12 closing price
Price
$7.21
Change
-$0.09 (-1.23%)
Capitalization
672.07M
80 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
MYGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Myriad Genetics (MYGN) Ownership - Who owns Myriad Genetics?

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual’s risk of developing a disease... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
320 Wakara Way
Phone
+1 801 584-3600
Employees
2700
Web
https://www.myriad.com

Details

Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
672.07M
P/E Ratio
N/A
Total Cash
145.4M
Projected Growth
N/A
Total Debt
212.3M
Revenue
825.3M
Risk (Beta)
2.17
Dividend Yield
N/A
Total Cash/Share
1.56
Total Debt/Equity
N/A
Revenue/Share
8.98 USD as % of share price

Fundamentals

MYGN
Capitalization
672M
P/E Ratio
N/A
Risk (Beta)
2.17
Dividend Yield
N/A
Total Cash
145M
Total Cash/Share
1.56
Total Debt
212M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
8.98%
Revenue
825M
ROE
N/A
Book Value
373M
P/B Ratio
1.80
Cash Flow
N/A
Earnings
-4.35
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
900K
Current Ratio
2.33
Current Revenue Per Employee
76185.19
Dividends Per Share - Security
N/A
EBITDA
-362.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
69.91
Revenue To Assets
-44.27
Shares Held By Institutions
2.78B
Shares Outstanding - Current
93.2M
Total Liabilities
355M
Total Volume MTD
N/A
Value
-1
Gain YTD
-46.754
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Earnings TradersEarnings Traders
Annualized Return+26%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
MYGN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MYGN showed earnings on November 03, 2025. You can read more about the earnings report here.
View AI-Driven Trading for MYGN
A.I. Advisor
published General Information

General Information

a developer of therapeutic and predictive medicine products

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
320 Wakara Way
Phone
+1 801 584-3600
Employees
2700
Web
https://www.myriad.com